Cascade Pharmaceuticals, Inc

This study is testing an experimental drug called CS0159 for people with Primary Sclerosing Cholangitis (PSC), a rare disease that scars the bile ducts in the liver. The main goal is to see if the drug is safe and if it can lower a key liver enzyme (ALP) over 12 weeks. The trial …

This study is testing an experimental drug called CS0159 for people with Primary Biliary Cholangitis (PBC), a chronic liver disease. It will involve 75 participants and last about one year, with the first 12 weeks comparing the drug to a placebo. The main goals are to see if CS01…

This is a very early-stage study to check the safety of a new drug called CS060304, which is being developed for a liver condition called MASH. The study will involve 80 healthy volunteers and people with high cholesterol to see how their bodies handle single and multiple doses o…